By RNA immunoprecipitation (RIP) using TDO2-specific antibodies and sequencing of the precipitated RNAs, the authors identified 645 known miRNAs and 138 novel miRNAs that can bind to TDO2 in human hepatocellular carcinoma (HCCLM3) cells. Here, TDO2 is linked to hepatocellular carcinoma.